Published in Ann Biomed Eng on February 17, 2010
Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ (2011) 1.53
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. Am J Physiol Heart Circ Physiol (2010) 1.18
Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function. J Appl Physiol (1985) (2010) 1.07
Pulmonary circulation at exercise. Compr Physiol (2012) 1.06
Impact of increased hematocrit on right ventricular afterload in response to chronic hypoxia. J Appl Physiol (1985) (2014) 0.83
Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia. Biomech Model Mechanobiol (2013) 0.80
Optimization of isolated perfused/ventilated mouse lung to study hypoxic pulmonary vasoconstriction. Pulm Circ (2013) 0.79
Characterization of the isolated, ventilated, and instrumented mouse lung perfused with pulsatile flow. J Vis Exp (2011) 0.78
Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension. J Appl Physiol (1985) (2016) 0.75
What does the time constant of the pulmonary circulation tell us about the progression of right ventricular dysfunction in pulmonary arterial hypertension? Pulm Circ (2015) 0.75
Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension. Exp Physiol (2013) 0.75
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol (2006) 2.83
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest (2007) 2.68
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J (2009) 2.63
Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation (2009) 2.17
PULMONARY VASCULAR IMPEDANCE IN THE DOG. Circ Res (1965) 2.05
Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol (2004) 1.90
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res (2006) 1.85
Haemodynamic evaluation of pulmonary hypertension. Eur Respir J (2002) 1.53
Characterization of airway and vascular responses in murine lungs. Br J Pharmacol (1999) 1.50
Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships. J Biomech (2006) 1.19
Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: effects of propofol and isoflurane. J Appl Physiol (1985) (1993) 1.07
Sympathetic control of pulmonary vascular impedance in anesthetized dogs. Circ Res (1971) 0.95
Pulmonary vascular resistance and impedance in isolated mouse lungs: effects of pulmonary emboli. Ann Biomed Eng (2006) 0.93
Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension. Am J Respir Crit Care Med (2002) 0.89
Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice. J Pharmacol Toxicol Methods (2005) 0.88
Impedance and transmission properties of the pulmonary arterial system. Cardiovasc Res (1971) 0.85
Effects of sildenafil on hypoxic pulmonary vascular function in dogs. J Appl Physiol (1985) (2006) 0.83
Analysis of pulsatile pulmonary artery blood flow in the unanesthetized dog. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.81
Effects of blood volume changes on characteristic impedance of the pulmonary artery. Am J Physiol (1982) 0.80
Pulse wave velocity in the main pulmonary artery of the dog. Circ Res (1967) 0.79
Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 5.31
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med (2002) 3.91
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med (2006) 3.14
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J (2012) 2.32
Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med (2014) 2.14
Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol (2013) 2.07
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation (2004) 1.79
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2002) 1.77
Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation (2003) 1.71
Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med (2004) 1.71
Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation (2013) 1.62
Exercise pathophysiology in patients with chronic mountain sickness exercise in chronic mountain sickness. Chest (2012) 1.59
Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol (2003) 1.58
Pulmonary circulation and gas exchange at exercise in Sherpas at high altitude. J Appl Physiol (1985) (2013) 1.55
Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ (2011) 1.53
Beta-adrenergic blockade and metabo-chemoreflex contributions to exercise capacity. Med Sci Sports Exerc (2008) 1.46
Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol (2004) 1.46
Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med (2010) 1.45
Acute pulmonary embolism: relationships between ground-glass opacification at thin-section CT and hemodynamics in pigs. Radiology (2009) 1.42
Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations. Eur Respir J (2012) 1.41
Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulation. Chest (2014) 1.40
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation (2013) 1.35
Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr (2012) 1.33
The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2010) 1.33
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.29
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol (2010) 1.25
Endothelin receptor antagonists. Pharmacol Ther (2005) 1.24
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.24
The mechanobiology of pulmonary vascular remodeling in the congenital absence of eNOS. Biomech Model Mechanobiol (2006) 1.21
Pulmonary vascular distensibility predicts aerobic capacity in healthy individuals. J Physiol (2012) 1.20
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest (2014) 1.20
Proximal pulmonary arterial obstruction decreases the time constant of the pulmonary circulation and increases right ventricular afterload. J Appl Physiol (1985) (2013) 1.19
Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships. J Biomech (2006) 1.19
Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.19
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. Am J Physiol Heart Circ Physiol (2010) 1.18
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. J Heart Lung Transplant (2011) 1.16
Tissue Doppler imaging evaluation of cardiac adaptation to severe pulmonary hypertension. Am J Cardiol (2007) 1.15
Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol (2003) 1.13
Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest (2006) 1.13
Effects of ischemia and myogenic activity on active and passive mechanical properties of rat cerebral arteries. Am J Physiol Heart Circ Physiol (2002) 1.10
Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation (2003) 1.08
Measurement to predict survival: the case of diastolic pulmonary gradient. JACC Heart Fail (2015) 1.07
A method for dynamic system characterization using hydraulic series resistance. Lab Chip (2006) 1.07
Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function. J Appl Physiol (1985) (2010) 1.07
Role of collagen content and cross-linking in large pulmonary arterial stiffening after chronic hypoxia. Biomech Model Mechanobiol (2011) 1.07
The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics. J Biomech (2010) 1.06
Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest (2012) 1.05
Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature. Ann Biomed Eng (2013) 1.03
Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension. Chest (2002) 1.03
Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. Chest (2004) 1.03
Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury. Crit Care Med (2002) 1.01
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol (2011) 1.00
Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension. Respir Med (2007) 0.99
Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia. Biomech Model Mechanobiol (2008) 0.99
Impact of acute pulmonary embolization on arterial stiffening and right ventricular function in dogs. Ann Biomed Eng (2012) 0.99
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol (2013) 0.99
Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke (2005) 0.98
Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Eur Heart J (2011) 0.97
In vivo and in vitro measurements of pulmonary arterial stiffness: A brief review. Pulm Circ (2012) 0.97
Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol (2005) 0.97
How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med (2007) 0.97
Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.96
Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med (2014) 0.96
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J (2002) 0.96
Mechanical properties of rat middle cerebral arteries with and without myogenic tone. J Biomech Eng (2004) 0.95
Persistent vascular collagen accumulation alters hemodynamic recovery from chronic hypoxia. J Biomech (2011) 0.95
Echocardiographic and tissue Doppler imaging of cardiac adaptation to high altitude in native highlanders versus acclimatized lowlanders. Am J Cardiol (2009) 0.94
Effects of collagen deposition on passive and active mechanical properties of large pulmonary arteries in hypoxic pulmonary hypertension. Biomech Model Mechanobiol (2013) 0.94
Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg (2009) 0.94
Pulmonary vascular resistance and impedance in isolated mouse lungs: effects of pulmonary emboli. Ann Biomed Eng (2006) 0.93
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J (2012) 0.92
Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension. PLoS One (2013) 0.92
Early activation of cardiac and renal endothelin systems in experimental heart failure. Am J Physiol Heart Circ Physiol (2003) 0.91
Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy. J Card Fail (2008) 0.91
Hyperoxia enhances metaboreflex sensitivity during static exercise in humans. Am J Physiol Heart Circ Physiol (2006) 0.91
Lung membrane conductance and capillary volume derived from the NO and CO transfer in high-altitude newcomers. J Appl Physiol (1985) (2013) 0.91
Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2005) 0.90
Chemoreflex and metaboreflex responses to static hypoxic exercise in aging humans. Med Sci Sports Exerc (2006) 0.90
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival. Chest (2008) 0.90
Serial changes in nasal potential difference and lung electrical impedance tomography at high altitude. J Appl Physiol (1985) (2002) 0.89
Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy. Circulation (2004) 0.89
Endothelin receptor blockade in canine oleic acid-induced lung injury. Intensive Care Med (2003) 0.88
Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure. J Appl Physiol (1985) (2010) 0.88
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med (2006) 0.88
Effects of sildenafil on exercise capacity in hypoxic normal subjects. High Alt Med Biol (2007) 0.88
Increased metaboreflex activity is related to exercise intolerance in heart transplant patients. Am J Physiol Heart Circ Physiol (2007) 0.87
Time course of intermittent hypoxia-induced impairments in resistance artery structure and function. Respir Physiol Neurobiol (2009) 0.87
Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg (2003) 0.87
Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension. Chest (2007) 0.87
Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med (2009) 0.86
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH. Eur Respir J (2012) 0.86
The Belgian Eisenmenger syndrome registry: implications for treatment strategies? Acta Cardiol (2009) 0.86